173 related articles for article (PubMed ID: 26687103)
1. Retrospective Analysis of Synthetic Cannabinoid Metabolites in Urine of Individuals Suspected of Driving Impaired.
Davies BB; Bayard C; Larson SJ; Zarwell LW; Mitchell RA
J Anal Toxicol; 2016 Mar; 40(2):89-96. PubMed ID: 26687103
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of Nine Synthetic Cannabinoid Receptor Agonists Encountered in Clinical Casework: Major in vivo Phase I Metabolites of AM-694, AM-2201, JWH-007, JWH-019, JWH-203, JWH-307, MAM-2201, UR-144 and XLR-11 in Human Urine Using LC-MS/MS.
Hutter M; Broecker S; Kneisel S; Franz F; Brandt SD; Auwarter V
Curr Pharm Biotechnol; 2018; 19(2):144-162. PubMed ID: 29745330
[TBL] [Abstract][Full Text] [Related]
3. Urinary prevalence, metabolite detection rates, temporal patterns and evaluation of suitable LC-MS/MS targets to document synthetic cannabinoid intake in US military urine specimens.
Wohlfarth A; Scheidweiler KB; Castaneto M; Gandhi AS; Desrosiers NA; Klette KL; Martin TM; Huestis MA
Clin Chem Lab Med; 2015 Feb; 53(3):423-34. PubMed ID: 25263309
[TBL] [Abstract][Full Text] [Related]
4. Determination of a selection of synthetic cannabinoids and metabolites in urine by UHPSFC-MS/MS and by UHPLC-MS/MS.
Berg T; Kaur L; Risnes A; Havig SM; Karinen R
Drug Test Anal; 2016 Jul; 8(7):708-22. PubMed ID: 26304456
[TBL] [Abstract][Full Text] [Related]
5. Quantitative urine confirmatory testing for synthetic cannabinoids in randomly collected urine specimens.
Castaneto MS; Scheidweiler KB; Gandhi A; Wohlfarth A; Klette KL; Martin TM; Huestis MA
Drug Test Anal; 2015 Jun; 7(6):483-93. PubMed ID: 25231213
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of synthetic cannabinoids in blood samples from Norwegian drivers suspected of impaired driving during a seven weeks period.
Tuv SS; Krabseth H; Karinen R; Olsen KM; Øiestad EL; Vindenes V
Accid Anal Prev; 2014 Jan; 62():26-31. PubMed ID: 24129318
[TBL] [Abstract][Full Text] [Related]
7. Determination of XLR-11 and its metabolites in hair by liquid chromatography-tandem mass spectrometry.
Park M; Yeon S; Lee J; In S
J Pharm Biomed Anal; 2015 Oct; 114():184-9. PubMed ID: 26070160
[TBL] [Abstract][Full Text] [Related]
8. Screening, quantification, and confirmation of synthetic cannabinoid metabolites in urine by UHPLC-QTOF-MS.
Gundersen POM; Spigset O; Josefsson M
Drug Test Anal; 2019 Jan; 11(1):51-67. PubMed ID: 29996011
[TBL] [Abstract][Full Text] [Related]
9. LC-QTOF-MS as a superior strategy to immunoassay for the comprehensive analysis of synthetic cannabinoids in urine.
Kronstrand R; Brinkhagen L; Birath-Karlsson C; Roman M; Josefsson M
Anal Bioanal Chem; 2014 Jun; 406(15):3599-609. PubMed ID: 24424965
[TBL] [Abstract][Full Text] [Related]
10. Validation of a novel immunoassay for the detection of synthetic cannabinoids and metabolites in urine specimens.
Arntson A; Ofsa B; Lancaster D; Simon JR; McMullin M; Logan B
J Anal Toxicol; 2013 Jun; 37(5):284-90. PubMed ID: 23625703
[TBL] [Abstract][Full Text] [Related]
11. Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls.
Möller I; Wintermeyer A; Bender K; Jübner M; Thomas A; Krug O; Schänzer W; Thevis M
Drug Test Anal; 2011 Sep; 3(9):609-20. PubMed ID: 20872894
[TBL] [Abstract][Full Text] [Related]
12. Analysis of new classes of recreational drugs in sewage: synthetic cannabinoids and amphetamine-like substances.
Reid MJ; Derry L; Thomas KV
Drug Test Anal; 2014; 6(1-2):72-9. PubMed ID: 23460377
[TBL] [Abstract][Full Text] [Related]
13. Concentrations of APINACA, 5F-APINACA, UR-144 and its degradant product in blood samples from six impaired drivers compared to previous reported concentrations of other synthetic cannabinoids.
Karinen R; Tuv SS; Øiestad EL; Vindenes V
Forensic Sci Int; 2015 Jan; 246():98-103. PubMed ID: 25485949
[TBL] [Abstract][Full Text] [Related]
14. Metabolic patterns of JWH-210, RCS-4, and THC in pig urine elucidated using LC-HR-MS/MS: Do they reflect patterns in humans?
Schaefer N; Helfer AG; Kettner M; Laschke MW; Schlote J; Ewald AH; Meyer MR; Menger MD; Maurer HH; Schmidt PH
Drug Test Anal; 2017 Apr; 9(4):613-625. PubMed ID: 27328899
[TBL] [Abstract][Full Text] [Related]
15. Molecularly imprinted polymer based quartz crystal microbalance sensor system for sensitive and label-free detection of synthetic cannabinoids in urine.
Battal D; Akgönüllü S; Yalcin MS; Yavuz H; Denizli A
Biosens Bioelectron; 2018 Jul; 111():10-17. PubMed ID: 29631158
[TBL] [Abstract][Full Text] [Related]
16. Nontargeted SWATH acquisition for identifying 47 synthetic cannabinoid metabolites in human urine by liquid chromatography-high-resolution tandem mass spectrometry.
Scheidweiler KB; Jarvis MJ; Huestis MA
Anal Bioanal Chem; 2015 Jan; 407(3):883-97. PubMed ID: 25224637
[TBL] [Abstract][Full Text] [Related]
17. Validation and application of an UPLC-MS/MS method for the quantification of synthetic cannabinoids in urine samples and analysis of seized materials from the Portuguese market.
Simões SS; Silva I; Ajenjo AC; Dias MJ
Forensic Sci Int; 2014 Oct; 243():117-25. PubMed ID: 25127518
[TBL] [Abstract][Full Text] [Related]
18. A sensitive GC-EIMS method for simultaneous detection and quantification of JWH-018 and JWH-073 carboxylic acid and hydroxy metabolites in urine.
Paul BD; Bosy T
J Anal Toxicol; 2015 Apr; 39(3):172-82. PubMed ID: 25691387
[TBL] [Abstract][Full Text] [Related]
19. Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in 'herbal mixtures' using LC-MS/MS techniques.
Hutter M; Broecker S; Kneisel S; Auwärter V
J Mass Spectrom; 2012 Jan; 47(1):54-65. PubMed ID: 22282090
[TBL] [Abstract][Full Text] [Related]
20. Monitoring of urinary metabolites of JWH-018 and JWH-073 in legal cases.
Jang M; Yang W; Choi H; Chang H; Lee S; Kim E; Chung H
Forensic Sci Int; 2013 Sep; 231(1-3):13-9. PubMed ID: 23890611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
